Caffeine as a Lead Compound for the Design of Therapeutic Agents for the Treatment of Parkinson’s Disease

Publisher: Bentham Science Publishers

E-ISSN: 1875-533x|22|8|975-988

ISSN: 0929-8673

Source: Current Medicinal Chemistry, Vol.22, Iss.8, 2015-03, pp. : 975-988

Disclaimer: Any content in publications that violate the sovereignty, the constitution or regulations of the PRC is not accepted or approved by CNPIEC.

Previous Menu Next

Abstract